These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37659242)

  • 1. Learning potential and visuospatial memory could predict amyloid-beta positron emission tomography positivity in amnestic mild cognitive impairment.
    Shin MG; Lee YM; Kim YJ; Lee H; Pak K; Choi KU
    Psychiatry Res Neuroimaging; 2023 Oct; 335():111705. PubMed ID: 37659242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine Learning for the Prediction of Amyloid Positivity in Amnestic Mild Cognitive Impairment.
    Kang SH; Cheon BK; Kim JS; Jang H; Kim HJ; Park KW; Noh Y; Lee JS; Ye BS; Na DL; Lee H; Seo SW
    J Alzheimers Dis; 2021; 80(1):143-157. PubMed ID: 33523003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological profile of amyloid-positive versus amyloid-negative amnestic Mild Cognitive Impairment.
    Alves L; Cardoso S; Silva D; Mendes T; Marôco J; Nogueira J; Lima M; Tábuas-Pereira M; Baldeiras I; Santana I; de Mendonça A; Guerreiro M
    J Neuropsychol; 2021 Apr; 15 Suppl 1():41-52. PubMed ID: 32588984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment.
    Kim SE; Woo S; Kim SW; Chin J; Kim HJ; Lee BI; Park J; Park KW; Kang DY; Noh Y; Ye BS; Yoo HS; Lee JS; Kim Y; Kim SJ; Cho SH; Na DL; Lockhart SN; Jang H; Seo SW
    J Alzheimers Dis; 2018; 66(2):681-691. PubMed ID: 30320571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
    Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
    Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques.
    Ezzati A; Harvey DJ; Habeck C; Golzar A; Qureshi IA; Zammit AR; Hyun J; Truelove-Hill M; Hall CB; Davatzikos C; Lipton RB;
    J Alzheimers Dis; 2020; 73(3):1211-1219. PubMed ID: 31884486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Amyloid Positivity Rate and Accumulation Pattern between Amnestic and Non-Amnestic Type Mild Cognitive Impairment.
    Lee SH; Lee JH; Byun MS; Yi D; Jung G; Park JE; Lee DY
    Psychiatry Investig; 2020 Jun; 17(6):603-607. PubMed ID: 32517418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Wang Y; Lou F; Li Y; Liu F; Wang Y; Cai L; Gordon ML; Zhang Y; Zhang N
    Curr Alzheimer Res; 2021; 18(6):523-532. PubMed ID: 34598664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a specific memory signature associated with Aβ-PET positivity in patients with amnestic mild cognitive impairment?
    Tomadesso C; Gonneaud J; Egret S; Perrotin A; Pélerin A; de Flores R; de la Sayette V; Desgranges B; Chételat G; La Joie R
    Neurobiol Aging; 2019 May; 77():94-103. PubMed ID: 30784816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation of neuropsychological evaluation with 11C-PiB and 18F-FC119S amyloid PET in mild cognitive impairment and Alzheimer disease.
    Park SY; Byun BH; Kim BI; Lim SM; Ko IO; Lee KC; Kim KM; Kim YK; Lee JY; Bu SH; Kim JH; Chi DY; Ha JH
    Medicine (Baltimore); 2020 Apr; 99(16):e19620. PubMed ID: 32311931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association of β-Amyloid with Cognition and Striatal Dopamine in Early, Non-Demented Parkinson's Disease.
    Oh YS; Yoo SW; Lyoo CH; Yoo JY; Yoon H; Ha S; Lee KS; Kim JS
    J Parkinsons Dis; 2021; 11(2):605-613. PubMed ID: 33646180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Subjective Memory Complaints Identify Aβ Positive and Aβ Negative Amnestic Mild Cognitive Impairment Patients?
    Mendes T; Cardoso S; Guerreiro M; Maroco J; Silva D; Alves L; Schmand B; Gerardo B; Lima M; Santana I; de Mendonça A
    J Alzheimers Dis; 2019; 70(4):1103-1111. PubMed ID: 31306132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential patterns of regional cerebral hypometabolism according to the level of cerebral amyloid deposition in patients with amnestic mild cognitive impairment.
    Jeon SY; Yi D; Byun MS; Choi HJ; Kim HJ; Lee JH; Baek H; Choe YM; Lee Y; Woo JI; Lee DY
    Neurosci Lett; 2016 Oct; 632():104-8. PubMed ID: 27574728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study.
    Pérez-Grijalba V; Arbizu J; Romero J; Prieto E; Pesini P; Sarasa L; Guillen F; Monleón I; San-José I; Martínez-Lage P; Munuera J; Hernández I; Buendía M; Sotolongo-Grau O; Alegret M; Ruiz A; Tárraga L; Boada M; Sarasa M;
    Alzheimers Res Ther; 2019 Dec; 11(1):96. PubMed ID: 31787105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the Female Advantage in Verbal Memory Contribute to Underestimating Alzheimer's Disease Pathology in Women versus Men?
    Sundermann EE; Biegon A; Rubin LH; Lipton RB; Landau S; Maki PM;
    J Alzheimers Dis; 2017; 56(3):947-957. PubMed ID: 28106548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Scale for Amyloid PET Positivity Based on Clinical and MRI Variables in Patients with Amnestic Mild Cognitive Impairment.
    Chun MY; Kim GH; Park HK; Yang DW; Kim S; Choi SH; Jeong JH
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743503
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Chun MY; Lee J; Jeong JH; Roh JH; Oh SJ; Oh M; Oh JS; Kim JS; Moon SH; Woo SY; Kim YJ; Choe YS; Kim HJ; Na DL; Jang H; Seo SW
    Yonsei Med J; 2022 Mar; 63(3):259-264. PubMed ID: 35184428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Brain Connectivity Using Network-Based Statistics in Amnestic Mild Cognitive Impairment Stratified by β-Amyloid Positivity.
    Kim JE; Kim SW; Choi M; Seong JK; Lee JH
    Am J Alzheimers Dis Other Demen; 2019 Mar; 34(2):104-111. PubMed ID: 30497273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological Testing Predicts Cerebrospinal Fluid Amyloid-β in Mild Cognitive Impairment.
    Kandel BM; Avants BB; Gee JC; Arnold SE; Wolk DA;
    J Alzheimers Dis; 2015; 46(4):901-12. PubMed ID: 25881908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Neural Correlates of Executive Function by Amyloid Positivity and Associations with Clinical Progression in Mild Cognitive Impairment.
    Yoon HJ; Kim SG; Kim SH; Choo ILH; Park SH; Seo EH;
    Yonsei Med J; 2019 Oct; 60(10):935-943. PubMed ID: 31538428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.